tgen Archives

TGen researchers uncover root of myeloma relapse

stem.cell

Researchers have discovered why multiple myeloma, a difficult to cure cancer of the bone marrow, frequently recurs after an initially effective treatment that can keep the disease at bay for up to several years. Working in collaboration with colleagues at Princess Margaret Hospital in Toronto, researchers from Mayo Clinic in Arizona and the Translational Genomics… Read More →

TGen Foundation plans two major fundraising events

medical.research

The Translational Genomics Research Institute (TGen) Foundation plans two climate-appropriate fundraising events — “Shop for a Cause” while it’s still hot, and “stepNout” when it cools off this fall. Mark your calendars for TGen’s 8th annual stepNout Run/Walk/Dash set for Nov. 3 at Kiwanis Park, 6111 S. All-America Way, in Tempe. Nearly 1,000 participants are… Read More →

$20,000 APS grant funds TGen education initiative

StemCellSciCamp08_5619

A $20,000 grant from the APS Foundation will help the Translational Genomics Research Institute (TGen) expand its TGen2School initiative by providing science kits and instruction in Science, Technology, Engineering and Math (STEM) education. The kits and accompanying instruction for teachers are part of the TGen2School initiative at TGen’s Pathogen Genomics Division – TGen North –… Read More →

Scientific internship helps build Arizona’s biomedical workforce

Krauss Honored For Science

Arizona’s future leaders in biology and medicine graduated today from one of the nation’s premier scientific internship programs, sponsored by Helios Education Foundation and the Translational Genomics Research Institute (TGen). The 45 interns in the 2013 Helios Scholars at TGen summer internship program completed eight weeks of biomedical investigations and presented their findings at a… Read More →

TGen-TD2-Scottsdale Healthcare study benefits patients

134127959

The Side-Out Foundation’s breast cancer pilot study, led by the Translational Genomics Research Institute (TGen), Translational Drug Development (TD2) and Scottsdale Healthcare, has shown that cancer patients do better when their treatment is guided by molecular profiling. Specifically, 52 percent of patients with advanced breast cancer received clinical benefit – meaning their disease was controlled… Read More →

TGen, Ventana announce research collaboration

medical.research

The Translational Genomics Research Institute (TGen) and Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced a collaborative research agreement to discover and develop diagnostic markers for treating cancer. The two Arizona-based institutions will leverage each other’s expertise in discovery and diagnostic product development, bringing innovative cancer diagnostic tests to patients.… Read More →

Ivy Foundation Grants Over $9M for Brain Cancer Research

prevention trial - brain scan images

The Ben & Catherine Ivy Foundation (Ivy Foundation) announced its 2012 grant recipients, which total more than $9 million in funding for brain cancer research. The Ivy Foundation is the largest privately funded brain cancer research foundation in North America. Catherine Ivy is the founder and president of the Ivy Foundation, which has a research… Read More →

TGen and Riddell Announce Partnership

head.injury
by in Featured | Healthcare | Sports

Head protection plays a vital role in the health and safety of any athlete participating in helmeted sports.  In a move that could help revolutionize football player safety, the Translational Genomics Research Institute (TGen), and Easton-Bell Sports through its Riddell brand, announced today it would work together on a study designed to advance athlete concussion… Read More →

Ivy Foundation Renews Support for TGen Program

Bioscience helix

The Arizona-based Ben & Catherine Ivy Foundation will fund a second year of the Ivy Neurological Science Internship Program at the Translational Genomics Research Institute (TGen). The internship program offers hands-on biomedical research experience for high school, undergraduate and aspiring medical school students pursuing careers in brain tumor research, neuroscience and neurogenomics. Through the program,… Read More →

TGen scientist launches innovative online research project

prevention trial - brain scan images

A scientific researcher at Phoenix-based Translational Genomics Research Institute (TGen) has launched a first-of-its-kind online memory test to help better understand human cognition and how it might relate to Alzheimer’s disease and other brain disorders. Dubbed “MindCrowd”, the study seeks to attract 1 million individuals, aged 18 to 80, willing to complete the 10-minute online… Read More →

Hispanic Chamber names Guerra Woman of the Year

guerra
by in Business News | Tech

The Arizona Hispanic Chamber of Commerce is honoring BioAccel CEO and Co-Founder MaryAnn Guerra as the Woman of the Year on Saturday at its 55th Annual Black & White Ball and Business Awards. Guerra is being recognized for BioAccel’s leadership role in economic development and its ongoing effort to start new companies and create jobs… Read More →

Foundation donates $500,000 for TGen research

medical.research
by in Bioscience | Featured | Healthcare

The Seena Magowitz Foundation has donated $500,000 from two charity golf tournaments dedicated to supporting pancreatic cancer research at the Translational Genomics Research Institute (TGen). Past donations from the Seena Magowitz Foundation have helped fund significant scientific research that is making a difference in the lives of pancreatic cancer patients and their families. In January,… Read More →

Medical miracle girl raises funds for TGen

medical.research

Shelby Valint, the 12-year-old Phoenix girl whose sequenced genome led her from a wheelchair to walking, is raising funds for the non-profit Translational Genomics Research Institute (TGen). The “Shelby Valint Inspiration Fundraiser” will generate needed research dollars for TGen’s Center for Rare Childhood Disorders (C4RCD). It was research through this innovative unit at TGen that… Read More →

FDA approved thyroid cancer drug tested by TGen

medical.research
by in Bioscience | Featured | Healthcare

The FDA has approved a thyroid cancer drug successfully tested at Virginia G. Piper Cancer Center Clinical Trials, a partnership of Scottsdale Healthcare and the Translational Genomics Research Institute (TGen). The U.S. Food and Drug Administration approved cabozantinib for the treatment of progressive, metastatic medullary thyroid cancer (MTC), a rare endocrine gland cancer affecting the… Read More →